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Abstract

Introduction

The effect of poly-L-aspartic acid (PA) on the crystal structure of calcium oxalate crystals grown after
spontaneous nucleation was evaluated as a function of
relative supersaturation and calcium:oxalate ratio in a
buffered salt solution, with pH and ionic strength in the
range of normal human urine. PA was used as a model
for naturally occurring acidic urine proteins that have
been shown to inhibit nucleation and growth of calcium
oxalate crystals. The crystals grown were characterized
by optical microscopy and X-ray powder diffraction. It
was observed that calcium oxalate monohydrate was the
preferred crystalline form in the absence of added PA,
and it was the only crystalline form obtained at most
conditions tested without PA. However, the presence of
PA favored the formation of calcium oxalate dihydrate
crystals, when present in adequate quantities. The quantity of PA required to affect this change in preferred
crystal structure was increased at higher supersaturations
and at lower calcium:oxalate ratios, exhibiting a non-linear dependence on both variables. PA was also shown
to be a kine.tic inhibitor of calcium oxalate dihydrate
crystallization. Aspartic acid monomer was found to
cause no change in the preferred structure of calcium
oxalate monohydrate at mass concentrations well beyond
those required with PA to obtain 100 % calcium oxalate
dihydrate, indicating the critical importance of the polymeric nature of PA for this effect on crystal structure.
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Conditions affecting the crystallization of calcium
oxalate (CaOx) in ionic solution are of critical importance for understanding nephrolithiasis (kidney stone disease) since CaOx is the dominant species found in these
pathologic crystals [13 , 14, 17]. One of the principle
questions in nephrolithiasis is by what mechanism does
the incipient crystal become trapped in the kidney, forming a symptomatic stone. Given the kinetic limitation to
stone formation by normal urine flow, a crystal must either evolve rapidly through a combination of nucleation,
growth and aggregation to yield a crystal mass that is
large enough to become physically trapped in the collecting system or adsorb to the tubular cell surface to allow
prolonged crystal mass accumulation [4]. CaOx crystals
are commonly found as either the monohydrate (COM)
or the dihydrate (COD) structure in patient samples [13 ,
14, 17). The structural difference may play a key role
in the regulation of nephrolithiasis, although no mechanism for such an effect has yet been established.
Data from several experiments suggest that COM
may have a greater tendency to form kidney stones than
COD. Previous studies of samples from patient have
shown that kidney stones are predominately COM, although COD crystals are also observed [ 13, 14, 17).
On the other hand, asymptomatic crystals in the urine
are usually COD, with COM found in some samples [6].
Laboratory experiments have shown that COM does bind
to inner medullary tubular cell membranes [15, 22), although similar experiments have not been published for
COD. Other experiments in the same laboratory demonstrate a stronger biological membrane interaction for
COM in its g_reater ability to lyse red blood cells compared to COD [21). In addition, theoretical calculations
of the degree of dimensional matching between crystal
lattice structures and head (charge) group distributions
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matches with COM than with COD crystals [12). These
varied results argue strongly for the possibility that the
formation of COD is protective against stone disease,
and the most likely mechanism for this effect would be

Key Words:

Calcium oxalate, polyaspartic acid,
nephrolithiasis, crystal inhibitors, crystal morphology,
crystallization.

415

J.A. Wesson and E. Worcester
reduced cell adhesion to the renal tubular cells. Therefore, it is important to understand the conditions that
favor COD formation.
Recently, there has been a lot of interest in urinary
molecules that have been shown to inhibit CaOx crystal
formation [4, 8) and thereby prevent crystal entrapment
by limiting crystal si:ze. Many of these molecules have
also been shown to influence the crystal structure, leading to the formation of COD rather than COM in typical
ionic solutions. Martin et al. [16) have shown that both
small molecule and macromolecule inhibitors found in
urine favor the formation of COD, and the unseparated
solutes from urine were more effective in this regard
than any of the single component inhibitors tested. The
small molecule inhibitors of citrate and pyrophosphate
accounted for less than half of the effect noted in the
urine solute samples. The known macromolecules tend
to be polyanions and are generally acidic in nature [7,
18). One such macromolecule found in human urine is
uropontin [18, 24), which has been shown to be an effective inhibitor of nucleation [23) and growth [24) of
CaOx crystals. Uropontin (or osteopontin) is a 44 kDa
protein [3], and occurs in rodent urine at a concentration
of about 8 µg/ml [5]. It contains 15-20% aspartic acid
units [5, 18, 24), including a run of 8-10 aspartic acid
units [5, 24), which is thought to be important to crystal
surface interactions, possibly in a specific manner [l, 2].
In the experiments described below, we explore the
effect of poly-L-aspartic acid (PA) on the structure of
CaOx crystals grown by spontaneous nucleation in ionic
solution at conditions of pH and ionic strength typical of
normal urine samples. The effect of PA on CaOx crystal structure is examined as a function of supersaturation
(SS) and calcium:oxalate (Ca:Ox) ratio in order to characteriz.e the phase diagram for this precipitation. PA has
been shown to be an effective kinetic inhibitor of CaOx
crystallization [11, 24), and specifically should be a convenient, inexpensive model for osteopontin. Due to the
dependence of nucleation rate on SS, the effective number of growing particles should increase with SS, and
hence, the inhibitor requirement should also increase.
The second independent parameter of Ca: Ox ratio has
been infrequently studied in vitro, but it will certainly influence surface charge densities of crystals and polyelectrolytes and, therefore, their interaction. Most experiments have been done under either equimolar conditions
or fixed non-stoichiometric ratios and do not elucidate
the dependence on Ca:Ox ratio. Normal human urine
has a significant excess of Ca ion with a Ca:Ox ratio in
the range of 6: 1 to 10: 1 [ 17). An even wider range of
ratios is seen when pathologic states are included.

without further purification. Solutions were prepared in
water that was deioni:zed and filtered using the Nanopure
system (Barnstead, Div. Sybron, Boston, MA). Crystals
were grown in an ionic buffer solution of 0.15 M NaCl
and 0.01 M HEPES (N-[2-Hydroxy]piperazine-N'-[2ethanesulfonic acid]) titrated to pH 7.5 with HCI.
Solutions were prepared by volumetric additions of stock
solutions to the appropriate quantity of deioni:zed water.
All solutions were equilibrated to room temperature
before mixing. Calcium ion was added by volumetric
addition of a 10 mM CaCl2 stock solution. Oxalate ion
was introduced from a 10 mM stock solution of
N½Ci0 4 . Typically, solutions were prepared to a total
volume of 10 ml in a new glass scintillation vial. Before
Ox ion addition, all other components, including any
inhibitors, were added to the container and thoroughly
mixed. Immediately following the addition of oxalate
ion, the solutions were shaken vigorously for iO to 15
seconds, and the precipitation was then allowed to occur
at room temperature (295 K ± 3 K) under quiescent
conditions. {Authors' note: Subsequent experiments
have shown a dependence of the concentration of PA
required to obtain COD on the lot of glass vials used for
the experiment. This presumably resulted from differences in PA surface adsorption to the different glass
vials, but we could eliminate this effect by pretreating
the vials with Gel Slick® (AT Biochem, Malvern, PA)}.
PA (Sigma, St. Louis, MO; molecular weight: 15
kDa) was added from a 0.138 mg/ml (9.23 µmolar)
stock solution again by volumetric addition. The volume
of inhibitor solution added was in excess of the 10 ml
total volume described above, and ion and inhibitor concentrations were corrected for this additional dilution.
The maximum change was 6.6% at the largest PA levels; however, for all but a few samples, this change was
less than 3 %. Aspartic acid monomer (Na salt; Sigma)
was prepared as an aqueous stock solution at the same
mass concentration as PA and added in the same way.
Samples were generally allowed to precipitate for
more than 3 hours or until an appreciable crystal mass
was observed, before examining the resulting crystals.
At the lowest supersaturations, the precipitations required 1 to 2 days before satisfying the latter requirement. No effort was made to verify the completeness of
the precipitation, but no difference was observed morphologically between crystals formed early in the precipitation reaction and those formed later, at several conditions. At the highest supersaturations, > 15, there was
visible crystal mass within one minute after addition of
Ox to the solution. Results for these conditions have
been included below for completeness, but we are concerned that the results for those conditions may have
been influenced by locally high concentrations of reagents, because of the limitations of mixing technique.

Materials and Methods
All chemicals were reagent grade and were used
416
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tate this response in terms of particle number, size and
distribution since the purpose of this experiment was to
test for changes in the kinetics, i.e., nucleation and
growth, of CaOx crystals. Again, time dependent signals were recorded with a chart recorder and digitized
for presentation.
X-ray powder diffraction was performed on thirty
samples selected from various solution compositions at
the National VA Crystal Identification Laboratory (Milwaukee, WI) to confirm the morphological identification. In general, microscopic examination of these samples was a much more sensitive measure of composition
than powder diffraction, allowing the identification of
even a single crystal of the non-dominant structure in a
field of thousands of the other type. In fact, no conditions were found to be purely one crystalline structure or
the other in microscopic examination. However, samples were considered to be pure in one structure if only
a few crystals, representing a trivial number fraction, of
the other structure were seen after examining the entire
area of the slide. Powder diffraction results were used
for samples demonstrating an ambiguous morphology
(e.g., equimolar with SS = 15.6 and with 616 nM PA).
This protocol was used throughout the experiment.
We calculated the SS by the following definition:

Crystals were isolated from solution by filtering
through PCTE (track-etched polycarbonate) filters (5.0
µm pore size, Poretics, Livermore, CA) in Swinney filter holders (Millipore, Bedford, MA). Filters were then
placed on a microscope slide with a drop of solution and
covered with a cover slide. Optical microscopy was
performed immediately on all samples using a Nikon
Optiphot-2 microscope (Nikon, Inc., Instrument Group,
Melville, NY), and photographs were taken of selected
samples with the attached camera system (Olympus Automatic Photomicrographic System PM-lOADS, Olympus Optical, Ltd., Tokyo, Japan). An effort was made
to examme the crystals over the entire area of each slide
by manually raster scanning the field because the relative
quantities of COM and COD crystals sometimes varied
from one field to another. At the lowest supersaturations, hundreds to thousands of crystals were seen in
each slide. Samples at supersaturations of 7 to 10
formed tens of thousands of crystals. For high supersaturation conditions, where an even larger crystal mass
was formed, dense piles of crystals were frequently
seen. The edges of such piles were examined thoroughly, but no effort was made to disperse these piles.
Crystal mass determinations were made on some
samples by filtering multiple, identically prepared samples and weighing the recovered crystal mass on an XA200DS analytical balance (Fisher Scientific, Pittsburgh,
PA). Filters used were the 5.0 µm PCTE filters as
above and 0.1 µm PCTE filters from the same manufacturer. After filtering the crystals and removing excess
solvent by pushing a small quantity of air through the
pre-weighed filters, the samples were further dried at
323 K for one hour. No change in crystal morphology
was noted with this drying protocol. Filter masses were
1.66 mg (standard deviation, SD, 0.05) and 0.89 mg
(SD 0.05) for the 5.0 µm and 0.1 µm filters, respectively. Standard deviation (SD) for repeated mass determination of a single filter was also 0.05 mg.
Ca ion concentration was determined with a calcium
selective electrode model F2112Ca with calomel reference electrode K401 and appropriate meter PHM82
(Radiometer A/S, Copenhagen, Denmark), and readings
were recorded with a chart recorder. The system was
calibrated with CaC12 solutions in the same buffer media
(0.15 M NaCl and 0.01 M HEPES) prepared by volumetric additions. Particle growth kinetics were determined by using a model LS-5 (Perkin-Elmer, Oak
Brook, IL) fluorescence spectrometer as a fixed angle
scattering photometer by setting both emission and ex citation wavelengths to 500 nm and both slit widths to 5
nm. Polystyrene cuvettes were used as sample cells.
The scattered intensity was minimal from the original
solutions, but rose rapidly with the appearance of crystals in the sample. No attempt bas been made to quanti-

SS

= {([Ca][Ox])/([Ca1o(Ox]o)}0.5

where [Ca] and [Ox] represent the initial ion concentrations for calciu,m and oxalate ions, respectively, in a
given solution and [Ca] 0 and [Ox]0 are the concentrations of those ions at equilibrium (calculated to be 0.15
mM for the temperature and buffer conditions above,
using the speciation program EQUIL2 (201). This quantity is more properly defined as the above ratio of activities; however, the solution ionic strength and pH conditions are dominated by the NaCl and HEPES buffer
components, with relatively small variations in the Ca
and Ox concentrations. Consequently, the correction
factors to calculate ionic activities are expected to cancel
with a very small error.

Results
In Figures 1, 2 and 3, examples of representative
fields for three samples are shown to illustrate the typical crystal habits seen for COM rich (Fig. 1, from a solution with a Ca:Ox ratio of 10: 1, at SS = 10.5 with no
PA added), COD rich (Fig. 2, from an equimolar sample at SS = 9.9 with 123 nM PA added) samples, and
mixed fields (Fig. 3, from an equimolar sample at SS =
13.2 with 123 nM PA added). All three micrographs
were taken from fields where the crystals had washed
off the surface of the filter for clarity of presentation.
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Figure 1. Optical micrograph of COM morphology typical of crystals grown with no PA added. This sample
resulted from the precipitation from 5.0 mM Ca with
0.5 mM Ox and no PA added (SS = 10.5).

Figure 3. Optical micrograph of mixture of COM and
COD morphologies formed simultaneously in the presence of intermediate concentrations of PA. This sample
resulted from the precipitation of 2.0 mM Ca with 2.0
mM Ox and 123 nM PA (SS = 13.2). The "starfish"
geometry of COD is seen near the center of Figure 3,
and it has a maximum linear dimension of about 15 µm.
Note that this condition was at the same quantity of added PA as shown in Figure 2, but at this higher SS, the
PA concentration was no longer sufficient to lead to
complete COD formation.
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The plate-like forms seen in Figure 1 were characteristic of the COM crystals formed under most conditions, although, at high supersaturations, the crystals became somewhat rounded at the ends and appeared to be
a bit thicker with a dimpling of the central portion suggestive of a "canoe" shape, as described previously [10].
Several crystals in Figure 3 show these characteristics.
The long axis of these crystals was typically in the range
of 5 to 20 µm. In many samples, aggregates of plates
were observed. Morphologic characterization was confirmed by X-ray powder diffraction for any variations
observed. While some variation of COM crystal morphology was observed at different conditions, COD
morphology was always as seen in Figures 2 and 3.
In Figure 2, the octahedral crystals characteristic of
COD are seen. Again, these crystals were usually in the
sire range of 5 to 20 µm in maximum dimension. In
Figure 3, not only are COM and COD forms seen, but
also a distorted octahedral form that looks like a fourarmed starfish. These were demonstrated to be COD
structures, likely a resultant from twinning, and were

0

Figure 2. Optical micrograph of COD morphology typical of crystals grown with a large concentration of PA.
This sample resulted from the precipitation of 1.5 mM
Ca with 1.5 mM Ox and 123 nM PA (SS = 9.9).

No differences were discernible between crystals that
remained on the filter and those that washed off.
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Figure 4. Crystal composition phase diagram for equimolar CaOx solutions, with the supersaturation plotted
along the abscissa and the concentration of PA on the
ordinate. The presence of COM crystals is indicated by
a filled square, while COD is indicated by an open circle. The "starfish" COD geometry is represented by an
eight-pointed star. Superimposed symbols at many intermediate conditions indicate the formation of both COM
and COD structures simultaneously at those conditions.

Figure 5. Crystal composition phase diagram for solutions with a ratio of Ca: Ox of 10: 1 plotted as in Figure
4. Filled square: COM crystals; open circle: COD
crystals; eight-pointed star: "starfish" COD geometry.

---------------------------hours (recovered crystal mass was the same at 4 hours).
No significant difference was observed. Given the uncertainties in weighing, we placed the unrecovered
weight fraction with a 5.0 µm filter at < 0.05. It is
important to note that X-ray powder diffraction data did
not show evidence of unrecognized crystal structures
(either COD in a sample felt to be pure COM, or vice
versa), suggesting that these small crystals were at least
the same structure as the larger crystals, if not a trivial
weight fraction of the total sample. In either case, further characterization of them would not affect our general conclusions, so further evaluation (e.g., by scanning
electron microscopy) was not pursued.
The crystal composition phase diagram for equimolar Ca and Ox is shown in Figure 4 as a function of SS
and [PA]. COM (filled squares) was formed exclusively
in the absence of PA. At sufficiently large [PA], at
most SS (i.e. , > 100 nM PA at SS = 10), COD (open
circles) was formed exclusively. The symbols were chosen in a manner to highlight the concentration of PA
above which COM was no longer observed. At low SS,
i.e. , 6 or below, the points are too closeIy spaced on
this scale to show it clearly, but the same qualitative picture was demonstrated. With no added PA, the samples
were pure COM, but pure COD was obtained by the addition of9.2 nM PA at SS of 4 and 18 nM PA at SS of
5. 3. A similar result was obtained by reducing the SS
at constant added PA, as illustrated in Figures 2 and 3.

most commonly observed in samples with intermediate
amounts of PA added and at higher SS. These crystalline forms tended to be slightly larger than the classic
COD forms, ranging up to about 25 µm in maximum
dimension, and they were frequently the first COD
forms seen with increasing concentration of PA.
There is a population of crystals seen in all three examples above that are too small to be adequately characterized by optical microscopy and clearly much smaller
than the 5.0 µm pore size of the filter. Since the particle size distributions were inherently broad, these were
felt to be representative of the compositional distribution
of the larger crystals seen. The small crystals appeared
to be a very small fraction of the total crystal mass by
optical microscopy, although these were collected on a
5.0 µm filter. To better gauge the significance of this
population of crystals in terms of weight fraction of the
total sample, a comparison was made between the crystal mass isolated with a 5.0 µm filter versus that obtained with a 0.1 µm filter. We observed 1. 15 mg (SD
0.06) recovered with a 5.0 µm filter and 1.18 mg (SD
0.10) recovered with a 0.1 µm filter from equimolar calcium oxalate solutions at SS = 9. 9 with 62 nM PA at 27
419
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This general pattern was reproduced at other Ca:Ox
ratios, although as this ratio increased, the amount of
PA required to obtain pure COD decreased. Figure 5
shows the comparable crystal composition phase diagram
at a Ca:Ox ratio of 10: 1. The same symbolic representation of data has been used to facilitate comparison of
data. One clear difference at higher Ca:Ox ratios was
the presence of significant, though still small, amounts
of COD crystals in samples with no PA added, consistent with the reduced need for PA to obtain COD . This
was more prominent at higher SS.
Figure 6 shows the dependence of crystal structure
on the Ca: Ox ratio and the amount of PA added for a SS
of 11.58 ± 0.05, using the same symbolic representations as above. The data are shown according to the interpretation by optical microscopy. The sample at 0.55
mM Ca and 360 nM PA had a significant, minor fraction of the crystal mass with ambiguous morphology .
Subsequent X-ray powder diffraction demonstrated that
COM was present in this sample, so the upward curvature suggested by this diagram at low Ca:Ox ratios , i.e. ,
1 or less, is certainly greater than that indicated in Figure 6. While our experiment emphasized the behavior
under normal urine conditions, which is fully included
in the range of Ca: Ox ratios sampled here, the dependence on Ca:Ox ratio is strongest at the lower extreme of
the data range. At the higher extreme, the amount of
PA required for formation of COD is apparently
independent of Ca:Ox ratio.
The effect of monomeric L-aspartic acid was also
examined at equimolar conditions and SS = 6.7. Crystals were grown in the presence of 5 µglml and 10
µglml of added aspartic acid monomer (corresponding
on a weight basis to the 0.33 and 0.66 µmolar PA solutions) , and the crystals obtained were indistinguishable
from those grown in the absence of any added inhibitors;
i.e. , pure COM. With the equivalent mass of PA, COD
was found at either of these concentrations (see Fig. 4).
Aspartic acid monomer may be an inhibitor at higher
concentrations, similar to citrate and pyrophosphate anions, but it is clearly less effective than PA in this regard. Evidently, the polymeric nature of the inhibitor is
a critical characteristic for the effects on crystal structure
demonstrated above.
To better understand the mechanism of the PA effect on CaOx crystallization, two additional experiments
were performed. A calcium selective electrode was used
to test for a decrease in the Ca ion activity with addition
of PA. The electrode was calibrated over the range of
0.1 mM to 10 mM Ca ion with a nearly linear increase
in voltage output per unit change in log([Ca]); slope =
30 mV/decade and intercept= 43 mV with [Ca] ion expressed in mM units. No difference was detectable in
the [Ca] ion at 1.0 mM between the presence or absence
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Figure 6. Crystal composition phase diagram for solutions at constant SS of 11.58 ± 0.05, but with varying
ratios of Ca:Ox. Ca concentration is plotted along the
abscissa, with the matching Ca:Ox ratio listed at the top
of each data column. The PA concentration is plotted
on the ordinate. Filled square: COM crystals; open circle: COD crystals; eight-pointed star: "starfish" COD
geometry.

The highest SS data apparently deviate from the pattern,
but this must be interpreted cautiously, given the kinetic
limitations of our experimental desiga, as described
above. The increase in the [PA] required to obtain
COD with increasing SS was dramatic.
At intermediate [PA], crystals of both types were
observed, and these regions are identifiable by the superposed symbols for various crystalline forms. The starfish form of COD (eight-pointed character) was also
found at high SS and intermediate amounts of PA (i.e. ,
SS > 10 and 100 nM PA). The relative ratio of COD
to COM was seen to increase systematically with the
amount of PA added. This behavior was also demonstrated at the highest SS, even though a condition showing pure COD was not clearly identified. Although no
effort was made to quaotitate the relative amount of
COD as a function of [PA], clearly, the transition from
favoring one crystalline form to favoring the other was
a gradual one, indicating a proportional response of
crystal structure to [PA]. The angulation of the data
toward the ordinate in the columns of nearly constant
supersaturation resulted from correcting for the dilution
from adding the PA stock solution.
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of 616 nM PA. The minimum detectable change was
expected to be 0.5 mV based on the variation in recorded potentials for independently prepared solutions, or
about a 4% change in the [Ca]. The [PA] corresponds
to 0.068 mM aspartic acid monomer units, so a detectable change even at this largest [PA] tested would require condensation of Ca ion on the chain past neutrality. Clearly, for the quantities of PA used in this study,
there was no appreciable effect on the Ca ion activity by
the addition of PA.
In a second experiment, the influence of [PA] on the
kinetics of COD crystallization was probed. Equimolar
solutions at 1.5 mM Ca and Ox (SS = 9.9) were prepared at four quantities of added PA: 0 nM, 123 nM,
246 nM and 492 nM. COM was formed with no added
PA, while the other three conditions lead to COD; the
123 nM condition was near to the lower boundary for
complete COD formation. The time dependence of the
scattered intensity is shown in Figure 7 for four representative precipitations. Data were not obtained during
the first 60 seconds due to mixing and solution transfer
issues. There was a clear progression toward longer lag
times with increasing [PA], and there appeared to be a
decrease in the initial slope. The increasing lag times
indicate an increasing delay in or slowing of nucleation.
The changes in the initial slope are likely related to differences in growth rates, but this conclusion is tenuous
given the known dependence of scattered intensity on the
number, size and shape of the growing crystals, and
none of these parameters were measured independently.
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Figure 7. The scattered intensity as a function of time
from solutions of 1.5 mM Ca with 1.5 mM Ox and varying amounts of added PA is plotted. Filled circle: no
added PA (formed COM); filled triangle: 123 nM PA
(formed COD); open diamond: 246 nM PA (formed
COD); filled square: 492 nM PA (formed COD). Data
for the first 60 seconds was not obtained due to limitations in our ability to mix the solutions and transfer them
to the instrument. Scattering was measured in a fluorescence spectrometer at a wavelength of 500 nm.

------------------------------------There was no evidence for conversion of one structure to the other, in particular COM to COD, in our observations. No difference was noticeable in the crystal
composition (COM:COD ratio) between samples crystallized for several hours and samples crystallized for
several days, although a transition from COD (a metastable structure) to COM might occur on a longer time
scale or under other conditions. Tested in a second
way, if the PA addition was made after Ox was added
to initiate the precipitation at a condition that would normally yield pure COD (e.g., equimolar at 1.5 mM Ca
and Ox; SS = 9.9 with 308 nM PA), a mixture of COM
and COD was obtained, providing that the addition of
PA was delayed until some crystal mass had formed in
the sample. Evidently, PA does not transform the COM
structure to COD, but it does prevent further development of COM, despite the presence of COM "seed"
crystals in the precipitating solution. Others have
proposed that COD forms first and is then converted to
COM [19], but we saw no evidence to support this interpretation in our experiments.
We favor the interpretation that the presence of PA
inhibits the growth of both COM and COD, but is more
effective against COM formation, so that COD becomes
the favored product for kinetic reasons. The study [16]

Discus.sion
The data presented above do not elucidate the mechanism of the interaction of PA with the growing crystal
mass that leads to the preferential formation of COD,
but several significant clues are evident.
There is a dramatic increase in PA requirement for
COD formation with increasing SS, implying a relationship between the number of nuclei and the amount of
polymer added. Unfortunately, quantitative data for the
number of nuclei formed under the various conditions
tested in this study are not yet available to allow a direct
comparison of the increase in PA with the increase in
number of crystal nuclei per unit volume. The gradual
transition from predominantly COM to predominantly
COD with increasing PA at a constant SS also suggests
a relationship between the polymer concentration and the
number of growing crystals or nuclei. The proportional
response to PA implies that PA must somehow be consumed in this process, either through binding to a nonpropagating COM nucleus or adherence to a COD crystal. Other reported inhibitors also demonstrate a proportional response [16].
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crystal nuclei, whether from PA or Ox. The high Ox
conditions reported here correspond to approximately a
100-fold excess of Ox to aspartic acid monomer units at
the highest [PA] used. Low Ox (high Ca) conditions
should then facilitate the effect of PA on crystal
structure. Our data, in Figure 6, clearly agree with the
inhibitor model. This is also consistent with in vivo data
showing that high [Ca] favors COD in crystalluria [6].
We conclude that the inhibitor model of interaction
is much more consistent with the available data. Since
COD can spontaneously form in solution at least at high
Ca concentrations, the differential change in the growth
rate of COM relative to COD may not need to be very
large to lead to preferential COD formation. However,
we cannot exclude the possibility that the polymer induces a change in the structure of the ionic cluster corresponding to the incipient crystal nucleus that allows it to
grow as a COD crystal, instead of COM, but this hypotheses fits less well with our data and with the published effects of other inhibitor molecules. Other mechanisms may also be possible. The implications for kidney stone disease may be significant, if subsequent experiments show a preferential formation of COD in the
presence of normal urinary macromolecules-like uropontin and a reduced affinity of COD for renal tubule cells,
compared to COM.
In summary, we have shown that PA, a model polyanion inhibitor of calcium oxalate crystal growth, favors
the formation of COD in supersaturated solutions of calcium and oxalate at pH = 7.5 and 0. 15 M NaCl. The
concentration of PA required to cause this change in preferred crystal structure increases with increasing supersaturation and decreases with increasing Ca:Ox ratio, in
a nonlinear manner in both instances. Also, the formation of COD is inherently favored by high Ca:Ox ratios.
The transition of crystalline forms is a smoothly varying
function of PA concentration, implying a stoichiometric
relationship to COM (or COD) crystal mass. PA has
also been shown to inhibit the kinetics of COD crystal
nucleation and growth. The effect of PA on the crystal
structure depends on the polymeric nature of the molecule, as monomeric aspartic acid has no effect on crystal
structure or morphology at similar mass concentrations.

cited above reported that kinetic inhibitors of COM favor COD formation, including urinary solutes, heparin,
RNA and small molecule inhibitors, such as citrate and
pyrophosphate. Another study [9] demonstrated that a
micellar anionic surfactant also inhibited crystal formation and favored the formation of COD in a spontaneous
nucleation experiment, while non-ionic and cationic micelles did not affect the crystal structure, although they
did influence crystallization kinetics (non-ionic micelles
facilitating and cationic micelles inhibiting crystallization). It is unlikely that these disparate compounds and
PA all manage to form a unique template surface to
stimulate the formation of the less favored COD structure. However, they are all anionic (or polyanionic),
and could be expected to condense on a cationic growing
crystal surface in a similar manner, possibly inhibiting
the growth of that surface. The relatively greater effectiveness of the polyanions would be consistent with their
inherently greater affinity through cooperativity for an
oppositely charged surface in this model, and with the
possibility that binding of one macromolecular structure
might cover the entire growing surface of an incipient
nucleus. Why PA and other inhibitors would be more
effective against COM than COD is not evident at this
time, but it must certainly depend on the surface characteristics of growing crystal faces.
An additional inference can be made from the behaviors observed as a function of Ca:Ox ratio, with respect to the relative merits of the template and inhibitor
models. Template growth should be favored by low Ca
(high Ox) conditions. If PA was acting as a template,
the first layer of ion condensation must be Ca. Since
the template generated structure (COD) must compete
for available Ca (and Ox) with spontaneous nucleation
which leads to COM, the natural ionic association of Ca
with PA could create locally high concentrations of Ca,
fostering template stimulated crystal formation at the expense of spontaneous nucleation (COM formation). On
the other hand, a large excess of Ca ion could saturate
the template sites, while still maintaining a large solution
Ca concentration to drive spontaneous nucleation and
COM formation, predicting an increased requirement for
PA with increasing Ca:Ox ratio. Of course, PA must
still be serving as an inhibitor of both COD and COM
growth at the same time it is serving as a template.
Conversely, in the inhibitor model, PA must compete
for the appropriate growing crystal face with other anions in solution (monomeric and polymeric), and its inhibitory effect should be reduced in the presence of
sufficiently high [Ox], through a competitive equilibrium
process. The cooperative binding advantage of PA is
proportional to the number of monomer units per chain,
but each carboxylic acid end group should have
essentially the same affinity for the charge sites on
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Discussion with Reviewers

L. Addacli: The "starfish" form of COD is treated as
a separate and important observation. This is, in my
opinion, just an effect of twinning that has been observed repeatedly in the literature of COD and is a very
common event in crystal growth.
G.H. Nancollas: The X-ray powder diffraction of the
"starfish" crystallites will be important.
Authors: We agree with the description of this "starfish" structure as a twinned COD crystal, but we have
not seen any published examples or description of conditions favoring its formation. We deduced the crystal
structure for this form by the following finding. We examined a sample (equimolar; SS = 13.2, 123 nM PA)
which was a mixture of "starfish" and normal COM
forms (no apparent normal COD forms) by microscopy;
we found the sample to be a mixture of COM and COD
by powder diffraction.
H.-G. Tiselius: The quantitation of the relative occurrence of COD and COM crystals in the precipitate is of
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ring apparatus, with little or no inhibitor present.

crucial importance and in view of the great number of
crystals, particularly at high levels of SS, it can be
assumed that this is not easy. A detailed description of
how the authors coped with this problem is desirable.
G.H. Nancollas: Did the authors use the X-ray diffraction technique in order to determine the exact percentage
of COM and COD? This can easily be achieved with
appropriate attention to standardization. This is particularly true in interpreting the data shown in Figures 4 and
5; it should be possible to quantify the amounts of different hydrates formed as a function of PA concentration.
L.C. Cao: The designed and used model system in vitro is semi-quantitative since neither light microscopy or
X-ray powder diffraction can give an accurate result
about COM/COD ratio.
Authors: We specifically avoided the question of numerical quantitation of the fractions of COM and COD
in these samples because of the difficulty in obtaining
these data. Dr. Neil Mandel, who is head of the National VA Crystal Identification Center in Milwaukee and
who donated the X-ray powder diffraction analyses to
our work, advised us that the use of powder diffraction
for quantitative analysis was possible, but extremely difficult, typically yielding data of limited precision. This
comment is echoed by Dr. Cao above, while Profs.
Nancollas and Tiselius are advocating powder diffraction
for this purpose. We defer any conclusions of the validity of this analytical method to these people since we are
not experts in this technique. Digital image analysis was
a second possibility, but unfortunately, it is not available
to us here. We are currently investigating the use of
Fourier-transform infrared spectroscopy (FTIR) for bulk
compositional analysis of calcium oxalate crystals, but it
too has limitations that we have not yet completely resolved. Consequently, we emphasize the point that the
addition of polyaspartate to the precipitation leads to a
structural change in the crystal formed. We also note
that the response to polyaspartate is a gradual one with
the addition of increasing amounts of polymer. Both of
these points are unambiguously made with our experiments. While we did not determine the functional dependence of crystal composition on polyaspartic acid addition, Martin et al. [16) showed essentially a linear
increase in COD with added inhibitors (both monomeric
and polymeric), and we anticipate a similar behavior for
our inhibitor based on our visual impression.

G.H. Nancollas: One has to be careful in identifying
phases by morphology. The crystals in Figure 1 appear
to be significantly twinned. Did the authors measure the
particle size distribution of the precipitated products
since some appear to be more aggregated than others?
Aggregation may well be a significant factor in the pathological formation of calcium oxalate deposits.
Authors: We agree that aggregation may be an important physiological issue, and we certainly see evidence
of it in our in vitro studies. However, we did not specifically follow this parameter since our focus was on
crystal structure in this study. When the crystal morphology did not allow for a straightforward identification
of the structure (which occurred in very few cases in our
experiments), we used powder diffraction as our absolute identification method.
G.H. Nancollas: It is important to recognize that the
crystal surface potential (zeta) will be sensitive both to
the adsorption of excess calcium ions and the adsorption
of PA. These will be opposing effects on the zeta potential and also on the degree of aggregation. The fact
that monomeric aspartic acid has no influence on the
phase formed again suggests that the surface potential
may be an important parameter to monitor.
Authors: We agree that the surface zeta potential is
likely a critical parameter in determining the crystal
interaction. These experiments would probably help
elucidate the nature of the polymer-crystal interaction,
but they are beyond the scope of this study.
S.R. Khan: Have you examined the impact of osteopontin on calcium oxalate crystal formation in vitro and
compared it with the effect of PA?
Authors: We are currently conducting experiments to
examine the influence of several macromolecules found
in urine, including osteopontin, on the crystal structure
of calcium oxalate crystals formed under similar conditions to those reported here. Osteopontin also affects the
crystal structure in a similar manner at physiologically
relevant concentrations. These experiments will be
described in detail in a subsequent publication.

H.-G. Tiselius: In these experiments, did you, under
any conditions, observe crystals of calcium oxalate trihydrate (COT)?
Authors: We did not find COT at any of the conditions
reported here. We have grown COT in our laboratory,
but only when stirring the samples with a magnetic stir424

